Dr. Farhad Khimani, MD
Claim this profileMoffitt Cancer Center
Area of expertise
Lymphoma
Farhad Khimani, MD has run 6 trials for Lymphoma. Some of their research focus areas include:
Myelodysplastic Syndrome
Farhad Khimani, MD has run 4 trials for Myelodysplastic Syndrome. Some of their research focus areas include:
Affiliated Hospitals
Moffitt Cancer Center
H. Lee Moffitt Cancer Center And Research Institute
Clinical Trials Farhad Khimani, MD is currently running
Ruxolitinib vs Prednisone
for Graft-versus-Host Disease
Allogeneic transplant is potentially curative for hematological malignancies but its use is limited by the development of GVHD. Ruxolitinib now has FDA approval for treatment of chronic GVHD that has failed 1-2 prior lines of therapy based on a prior large, randomized phase III study. Given this evidence of safety and efficacy in the early refractory setting (after prednisone failure), Ruxolitinib represents an ideal agent to test in the primary therapy setting. Here investigators propose a phase 2 randomized study to compare Ruxolitinib to prednisone as a first-line therapy in the treatment of chronic GVHD.
Recruiting
1 award
Phase 2
3 criteria
Pirtobrutinib + CAR T-cell Therapy
for Mantle Cell Lymphoma
This is a phase 2, open-label, randomized, multicenter clinical trial in patients with relapsed/refractory mantle cell lymphoma (R/R MCL) who meet the criteria for standard-of-care FDA label for CD19 CAR T-cell therapy with brexucabtagene autoleucel (brexu-cel).
Recruiting
1 award
Phase 2
4 criteria
More about Farhad Khimani, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Farhad Khimani, MD has experience with
- Fludarabine
- Tacrolimus
- Cyclophosphamide
- Mycophenolate Mofetil
- Total-body Irradiation
- Melphalan
Breakdown of trials Farhad Khimani, MD has run
Lymphoma
Myelodysplastic Syndrome
Acute Myeloid Leukemia
Acute Myelogenous Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Farhad Khimani, MD specialize in?
Farhad Khimani, MD focuses on Lymphoma and Myelodysplastic Syndrome. In particular, much of their work with Lymphoma has involved HLA-A negative patients, or patients who are HLA-A positive.
Is Farhad Khimani, MD currently recruiting for clinical trials?
Yes, Farhad Khimani, MD is currently recruiting for 5 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Farhad Khimani, MD has studied deeply?
Yes, Farhad Khimani, MD has studied treatments such as Fludarabine, Tacrolimus, Cyclophosphamide.
What is the best way to schedule an appointment with Farhad Khimani, MD?
Apply for one of the trials that Farhad Khimani, MD is conducting.
What is the office address of Farhad Khimani, MD?
The office of Farhad Khimani, MD is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.